https://edgen.pre.edgen.tech/news/post/cameco-keeps-uranium-output-at-215-million-pounds-on-ap1000-demand2026-08-03T15:30:01.095Zdaily1Edgen Stocken2026-08-03T15:30:01.095+00:00Cameco keeps uranium output at 21.5 million pounds on AP1000 demandhttps://static.edwealth.ai/news/images/cameco-keeps-uranium-output-at-215-million-pounds-on-ap1000-demand-20260803.pngCameco keeps uranium output at 21.5 million pounds on AP1000 demand https://edgen.pre.edgen.tech/news/post/banks-sell-crash-puts-to-hedge-250-billion-leveraged-etf-risk2026-08-03T15:25:40.574Zdaily1Edgen Stocken2026-08-03T15:25:40.574+00:00Banks Sell Crash Puts to Hedge $250 Billion Leveraged ETF Riskhttps://static.edwealth.ai/news/images/banks-sell-crash-puts-to-hedge-250-billion-leveraged-etf-risk-20260803.pngBanks Sell Crash Puts to Hedge $250 Billion Leveraged ETF Risk https://edgen.pre.edgen.tech/news/post/us-treasury-to-hold-issuance-guidance-as-30-year-yield-hits-5272026-08-03T15:21:47.910Zdaily1Edgen Stocken2026-08-03T15:21:47.910+00:00US Treasury to Hold Issuance Guidance as 30-Year Yield Hits 5.27%https://static.edwealth.ai/news/images/us-treasury-to-hold-issuance-guidance-as-30-year-yield-hits-527-20260803.pngUS Treasury to Hold Issuance Guidance as 30-Year Yield Hits 5.27% https://edgen.pre.edgen.tech/news/post/copper-floods-into-us-at-200000-tonnes-as-tariff-decision-looms2026-08-03T15:04:11.639Zdaily1Edgen Stocken2026-08-03T15:04:11.639+00:00Copper floods into US at 200,000 tonnes as tariff decision loomshttps://static.edwealth.ai/news/images/copper-floods-into-us-at-200000-tonnes-as-tariff-decision-looms-20260803.pngCopper floods into US at 200,000 tonnes as tariff decision looms https://edgen.pre.edgen.tech/news/post/micron-sk-hynix-fall-6-as-cxmt-weighs-second-dram-fab2026-08-03T14:58:06.763Zdaily1Edgen Stocken2026-08-03T14:58:06.763+00:00Micron, SK Hynix fall 6% as CXMT weighs second DRAM fabhttps://static.edwealth.ai/news/images/micron-sk-hynix-fall-6-as-cxmt-weighs-second-dram-fab-20260803.pngMicron, SK Hynix fall 6% as CXMT weighs second DRAM fab https://edgen.pre.edgen.tech/news/post/intuit-faces-securities-suit-after-turbotax-growth-misses-8-target2026-08-03T14:56:32.510Zdaily1Edgen Stocken2026-08-03T14:56:32.510+00:00Intuit faces securities suit after TurboTax growth misses 8% targethttps://static.edwealth.ai/news/images/intuit-faces-securities-suit-after-turbotax-growth-misses-8-target-20260803.pngIntuit faces securities suit after TurboTax growth misses 8% target https://edgen.pre.edgen.tech/news/post/first-solar-faces-aug-24-lawsuit-deadline-after-6076-share-slide2026-08-03T14:54:20.704Zdaily1Edgen Stocken2026-08-03T14:54:20.704+00:00First Solar faces Aug 24 lawsuit deadline after $60.76 share slidehttps://static.edwealth.ai/news/images/first-solar-faces-aug-24-lawsuit-deadline-after-6076-share-slide-20260803.pngFirst Solar faces Aug 24 lawsuit deadline after $60.76 share slide https://edgen.pre.edgen.tech/news/post/trumps-iran-talks-to-begin-monday-as-oil-slides-62026-08-03T14:50:42.493Zdaily1Edgen Stocken2026-08-03T14:50:42.493+00:00Trump's Iran talks to begin Monday as oil slides 6%https://static.edwealth.ai/news/images/trumps-iran-talks-to-begin-monday-as-oil-slides-6-20260803.pngTrump's Iran talks to begin Monday as oil slides 6% https://edgen.pre.edgen.tech/news/post/us-manufacturing-pmi-jumps-to-556-as-ai-boom-fuels-demand2026-08-03T14:49:55.066Zdaily1Edgen Stocken2026-08-03T14:49:55.066+00:00US manufacturing PMI jumps to 55.6 as AI boom fuels demandhttps://static.edwealth.ai/news/images/us-manufacturing-pmi-jumps-to-556-as-ai-boom-fuels-demand-20260803.pngUS manufacturing PMI jumps to 55.6 as AI boom fuels demand https://edgen.pre.edgen.tech/news/post/jpmorgan-chase-commits-750-billion-to-boost-us-housing-supply2026-08-03T14:47:45.127Zdaily1Edgen Stocken2026-08-03T14:47:45.127+00:00JPMorgan Chase commits $750 billion to boost US housing supplyhttps://static.edwealth.ai/news/images/jpmorgan-chase-commits-750-billion-to-boost-us-housing-supply-20260803.pngJPMorgan Chase commits $750 billion to boost US housing supply https://edgen.pre.edgen.tech/news/post/enterprise-products-q2-profit-jumps-27-on-record-volumes-and-exports2026-08-03T14:34:03.745Zdaily1Edgen Stocken2026-08-03T14:34:03.745+00:00Enterprise Products Q2 profit jumps 27% on record volumes and exportshttps://static.edwealth.ai/news/images/enterprise-products-q2-profit-jumps-27-on-record-volumes-and-exports-20260803.pngEnterprise Products Q2 profit jumps 27% on record volumes and exports https://edgen.pre.edgen.tech/news/post/verra-mobility-faces-aug-4-lead-plaintiff-deadline-after-71-crash2026-08-03T14:28:05.872Zdaily1Edgen Stocken2026-08-03T14:28:05.872+00:00Verra Mobility faces Aug 4 lead plaintiff deadline after 71% crashhttps://static.edwealth.ai/news/images/verra-mobility-faces-aug-4-lead-plaintiff-deadline-after-71-crash-20260803.pngVerra Mobility faces Aug 4 lead plaintiff deadline after 71% crash https://edgen.pre.edgen.tech/news/post/equipmentshare-faces-class-action-over-77-million-related-party-deals2026-08-03T14:26:42.713Zdaily1Edgen Stocken2026-08-03T14:26:42.713+00:00EquipmentShare faces class action over $77 million related-party dealshttps://static.edwealth.ai/news/images/equipmentshare-faces-class-action-over-77-million-related-party-deals-20260803.pngEquipmentShare faces class action over $77 million related-party deals https://edgen.pre.edgen.tech/news/post/insulet-faces-fraud-suit-as-omnipod-recalls-cut-stock-122026-08-03T14:25:36.886Zdaily1Edgen Stocken2026-08-03T14:25:36.886+00:00Insulet faces fraud suit as Omnipod recalls cut stock 12%https://static.edwealth.ai/news/images/insulet-faces-fraud-suit-as-omnipod-recalls-cut-stock-12-20260803.pngInsulet faces fraud suit as Omnipod recalls cut stock 12% https://edgen.pre.edgen.tech/news/post/zevra-therapeutics-falls-25-as-ema-rejects-arimoclomol-in-npc-re-examination2026-08-03T14:23:01.466Zdaily1Edgen Stocken2026-08-03T14:23:01.466+00:00Zevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examinationhttps://static.edwealth.ai/news/images/zevra-therapeutics-falls-25-as-ema-rejects-arimoclomol-in-npc-re-examination-20260803.pngZevra Therapeutics falls 25% as EMA rejects arimoclomol in NPC re-examination https://edgen.pre.edgen.tech/news/post/byd-denza-z9s-opens-pre-orders-from-47100-with-1100-km-range2026-08-03T14:21:20.566Zdaily1Edgen Stocken2026-08-03T14:21:20.566+00:00BYD Denza Z9S opens pre-orders from $47,100 with 1,100-km rangehttps://static.edwealth.ai/news/images/byd-denza-z9s-opens-pre-orders-from-47100-with-1100-km-range-20260803.pngBYD Denza Z9S opens pre-orders from $47,100 with 1,100-km range https://edgen.pre.edgen.tech/news/post/us-manufacturing-pmi-jumps-to-556-fastest-pace-since-20222026-08-03T14:20:18.670Zdaily1Edgen Stocken2026-08-03T14:20:18.670+00:00US manufacturing PMI jumps to 55.6, fastest pace since 2022https://static.edwealth.ai/news/images/us-manufacturing-pmi-jumps-to-556-fastest-pace-since-2022-20260803.pngUS manufacturing PMI jumps to 55.6, fastest pace since 2022 https://edgen.pre.edgen.tech/news/post/strategy-sells-1638-btc-for-1047-million-as-mstr-slides-412026-08-03T14:20:14.762Zdaily1Edgen Stocken2026-08-03T14:20:14.762+00:00Strategy sells 1,638 BTC for $104.7 million as MSTR slides 41%https://static.edwealth.ai/news/images/strategy-sells-1638-btc-for-1047-million-as-mstr-slides-41-20260803.pngStrategy sells 1,638 BTC for $104.7 million as MSTR slides 41% https://edgen.pre.edgen.tech/news/post/natural-gas-futures-hold-near-271-as-heat-boosts-power-demand2026-08-03T14:17:38.243Zdaily1Edgen Stocken2026-08-03T14:17:38.243+00:00Natural Gas Futures Hold Near $2.71 as Heat Boosts Power Demandhttps://static.edwealth.ai/news/images/natural-gas-futures-hold-near-271-as-heat-boosts-power-demand-20260803.pngNatural Gas Futures Hold Near $2.71 as Heat Boosts Power Demand https://edgen.pre.edgen.tech/news/post/ascletis-starts-phase-iii-obesity-trial-enrolling-4600-patients2026-08-03T13:58:51.291Zdaily1Edgen Stocken2026-08-03T13:58:51.291+00:00Ascletis starts Phase III obesity trial enrolling 4,600 patientshttps://static.edwealth.ai/news/images/ascletis-starts-phase-iii-obesity-trial-enrolling-4600-patients-20260803.pngAscletis starts Phase III obesity trial enrolling 4,600 patients